Measuring adherence to respiratory rehabilitation in lung cancer patients
Official title: Construction and Psychometric Properties of the Therapeutic Adherence Scale for Respiratory Rehabilitation in Lung Cancer (STA-RR-LC).
Run by Instituto Nacional de Cancerologia de Mexico · NCT06477302 · Data updated 2026-11-12
This study is testing a new questionnaire to see how well lung cancer patients in Mexico are sticking to their respiratory rehabilitation programs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 281 (estimated) |
| Sponsor | Instituto Nacional de Cancerologia de Mexico Academic / other |
| Locations | 1 site (Mexico City, Mexico City) |
| Status | Recruiting |
| Started | June 23, 2023 |
| Main results expected | June 23, 2026 |
| Study ends | June 23, 2027 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT06477302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old diagnosed with lung cancer who are currently undergoing respiratory rehabilitation treatment.
✕Probably not a fit
Patients with severe psychiatric conditions, significant hearing or visual impairments, or cognitive issues that hinder their understanding of the study will not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to construct and validate the Scale of Therapeutic Adherence for Respiratory Rehabilitation in patients diagnosed with lung cancer in Mexico. Participants will complete a 56-item questionnaire designed to assess their adherence to respiratory rehabilitation protocols. The study focuses on determining the reliability and validity of this scale among patients currently undergoing assessment or follow-up in a respiratory rehabilitation program. By evaluating therapeutic adherence, the study seeks to improve rehabilitation outcomes for lung cancer patients.
Why it matters
Potential benefit: If successful, this study could enhance the effectiveness of respiratory rehabilitation programs for lung cancer patients by providing a reliable tool to measure adherence.
How similar studies have gone: While the approach of measuring therapeutic adherence is common, the specific scale being validated in this study is novel and has not been previously tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with lung cancer (SCLC and NSCLC). * Over 18 years of age. * Voluntary participation by understanding and accepting the informed consent letter. * Patients undergoing Respiratory Rehabilitation treatment with one month assessment and follow-up. * Patients in active medical treatment. * Any clinical stage. * Karnofsky Index ≥ 70. Exclusion Criteria: * Severe hearing or visual problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the clinical record file). * Severe psychiatric conditions (schizophrenia or psychotic disorders) and/or addiction to any psychoactive substance (this will be identified as reported in the INCanet file). * Attentional or memory problems that prevent them from understanding the instructions and answering the instruments (this will be identified as reported in the INCanet file).
Where it's running
-
Instituto Nacional de Cancerologia
Mexico City, Mexico City, Mexico Recruiting
Study contacts
- Principal investigator: Oscar G Arrieta, MD — Instituto Nacional de Cancerologia (INCan) Mexico
- Study coordinator: Oscar G Arrieta, MD
- Email: ogar@unam.mx
- Phone: +52 55 5628 0400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.